NEW YORK (GenomeWeb) – The New York Stem Cell Foundation has offered details on its $25 million project to automate the production of induced pluripotent stem cells (iPSCs) and create "populations-on-a-chip."

A paper in Nature Methods, published August 3, details the steps in the industrial-scale production of cells for NYSCF's Global Stem Cell array, a product that has already attracted numerous collaborators and could speed up research on genetic diseases and drug development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.